{"id":"piperacetazine","_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=PIPERACETAZINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T04:22:02.885221+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T04:22:08.569087+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PIPERACETAZINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T04:22:08.948529+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Dopamine D2 receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:22:10.005741+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1584/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T04:22:09.658497+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T00:37:44.954Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:22:11.240566+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"REBOUND EFFECT"},{"count":2,"reaction":"UVEITIS"},{"count":1,"reaction":"ACUTE KIDNEY INJURY"},{"count":1,"reaction":"BONE MARROW FAILURE"},{"count":1,"reaction":"CEREBROVASCULAR ACCIDENT"},{"count":1,"reaction":"CLOSTRIDIUM TEST POSITIVE"},{"count":1,"reaction":"CORONARY ARTERY DISEASE"},{"count":1,"reaction":"DEHYDRATION"},{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"HAEMODIALYSIS"}],"crossReferences":{"chemblId":"CHEMBL1584"},"_approvalHistory":[],"publicationCount":42,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"approved","brandName":"PIPERACETAZINE","genericName":"PIPERACETAZINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1969","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T04:22:11.240566+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":false,"score":0}}